study intervention
|
OBI_0000931 |
[the part of the execution of an intervention design study which is varied between two or more subjects in the study] |
PMVK
|
OGG_3000010654 |
|
XBP1
|
OGG_3000007494 |
|
mitochondrial dysfunction
|
TXPO_0002361 |
[Mitochondrial dysfunction is a subtype of dysfunctioning: A process that performs an abnormal and incomplete mitochondrial function.] |
atrophy
|
MPATH_127 |
[A reduction in size of organs or tissues as a result of cell death, loss of cellularity of whatever cause, reduced cellular proliferation or decreased cellular volume.] |
CELF1
|
OGG_3000010658 |
|
2,3-epoxysqualene
|
CHEBI_78662 |
[A squalene triterpenoid obtained by formal epoxidation across the 2,3 C=C bond of squalene.] |
organ system subdivision
|
UBERON_0011216 |
[A subdivision of an anatomical system.] |
X-Ray Imaging
|
NCIT_C38101 |
[A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation.] |
heteropolycyclic compound
|
CHEBI_33671 |
[A polycyclic compound in which at least one of the rings contains at least one non-carbon atom.] |
posterior cingulate cortex
|
UBERON_0022353 |
[Component of the cingulate cortex. The rostral and caudal extent were the caudal anterior and the isthmus divisions of the cingulate cortex respectively. The medial and lateral boundaries were the corpus callosum and as the superior frontal gyrus and/or paracentral lobule respectively (Christine Fennema-Notestine).] |
TREM1
|
OGG_3000054210 |
|
CYCS
|
OGG_3000054205 |
|
LEF1
|
OGG_3000051176 |
|
TFCP2
|
OGG_3000007024 |
|
cardiovascular agent therapy
|
MAXO_0000181 |
[Use of a drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume.] |
sulfone
|
CHEBI_35850 |
[An organosulfur compound having the structure RS(=O)2R (R =/= H).] |
TREM2
|
OGG_3000054209 |
|
promazine
|
CHEBI_8459 |
[A phenothiazine deriative in which the phenothiazine tricycle has a 3-(dimethylaminopropyl) group at the N-10 position.] |
FAS
|
OGG_3000000355 |
|